Quarter Ended Mar 31, 2025
Net sales were up 2% to $113.2 million compared to $111.0 million (up 5% in constant currency).
GAAP net income attributable to common shareholders was up 104% to $4.7 million, or $0.25 per diluted common share, compared to $2.3 million, or $0.12 per diluted common share.
Adjusted EBITDA was up 20% to $11.0 million compared to $9.2 million.
For complete information regarding our financials, see our periodic filings.